71 results
8-K
EX-99.1
CLDX
Celldex Therapeutics Inc.
14 May 08
Departure of Directors or Principal Officers
12:00am
& Policy Council of the MIT Center for Biomedical Innovation and is a Research Professor of Medicine at Boston University School of Medicine and serves
8-K
EX-99
CLDX
Celldex Therapeutics Inc.
30 Apr 03
Financial statements and exhibits
12:00am
Small Business Innovation Research (SBIR) grant to support further
preclinical development of Ty800, the company's single dose, oral
typhoid vaccine
8-K
EX-99.1
CLDX
Celldex Therapeutics Inc.
1 Nov 12
Celldex Reports Third Quarter 2012 Financial Results
12:00am
received a new Small Business Innovation Research (SBIR) contract award totaling approximately $200,000 from the National Cancer Institute to develop
8-K
EX-99.1
CLDX
Celldex Therapeutics Inc.
10 Aug 12
Celldex Reports Second Quarter 2012 Financial Results
12:00am
Business Innovation Research (SBIR) grant in collaboration with The Rockefeller University.
R&D expenses in the second quarter of 2012 and 2011 were
8-K
EX-99.1
dt2 3o9xat
1 Nov 06
Results of Operations and Financial Condition
12:00am
10-K
tcse93
26 Mar 97
Annual report
12:00am
8-K/A
47vloa2u
29 Sep 98
Avant Immunotherapeutics, Inc. Form 8-K/A
12:00am